About 10% of people with cystic fibrosis – most of whom have two rare and/or nonsense mutations – are not eligible for any of the currently available CFTR protein modulator drugs. If you are living with a rare or nonsense mutation, if you’re caring for or partnered with someone who is, or if you’re just curious, come learn from the experts about the innovative and varied scientific research underway to ensure that 100% of people with CF have treatments for the underlying cause of the disease.